Roberts, Glore & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
3,240
-1,909
| -37% | -$133K | 0.07% | 189 |
|
|
2025
Q1 | $378K | Hold |
5,149
| – | – | 0.12% | 145 |
|
|
2024
Q4 | $337K | Buy |
5,149
+503
| +11% | +$33K | 0.1% | 155 |
|
|
2024
Q3 | $362K | Hold |
4,646
| – | – | 0.1% | 154 |
|
|
2024
Q2 | $362K | Sell |
4,646
-133
| -3% | -$10.4K | 0.11% | 148 |
|
|
2024
Q1 | $324K | Hold |
4,779
| – | – | 0.1% | 156 |
|
|
2023
Q4 | $322K | Hold |
4,779
| – | – | 0.1% | 151 |
|
|
2023
Q3 | $324K | Hold |
4,779
| – | – | 0.11% | 147 |
|
|
2023
Q2 | $342K | Sell |
4,779
-230
| -5% | -$16.5K | 0.11% | 145 |
|
|
2023
Q1 | $348K | Buy |
5,009
+75
| +2% | +$5.21K | 0.12% | 142 |
|
|
2022
Q4 | $335K | Sell |
4,934
-371
| -7% | -$25.2K | 0.12% | 140 |
|
|
2022
Q3 | $291K | Sell |
5,305
-542
| -9% | -$29.7K | 0.1% | 147 |
|
|
2022
Q2 | $386K | Sell |
5,847
-244
| -4% | -$16.1K | 0.13% | 135 |
|
|
2022
Q1 | $404K | Sell |
6,091
-1,946
| -24% | -$129K | 0.12% | 143 |
|
|
2021
Q4 | $468K | Buy |
8,037
+97
| +1% | +$5.65K | 0.12% | 133 |
|
|
2021
Q3 | $477K | Buy |
+7,940
| New | +$477K | 0.15% | 127 |
|